{
  "docId": "019dd923-622c-750b-8b97-9fb7a842e09f",
  "docSlug": "cddb6c0b289f",
  "documentTitle": "Eurofins Scientific SE (ERF)",
  "authorId": "51_Muddy_Waters",
  "authorName": "Carson C. Block",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2024-06-24 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 20,
  "pageCount": 36,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses investigative research-note style to highlight potential conflicts of interest and governance failures.",
  "elementsJson": [
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b97-9fb7a842e09f/20",
  "deckHref": "/decks/019dd923-622c-750b-8b97-9fb7a842e09f",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b97-9fb7a842e09f.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b97-9fb7a842e09f#slide-20",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Optimizing a large public company for malfeasance presumably requires a loyal inner circle who is willing to overlook problems – if not outright participate in them.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b333-ef3b3a36422b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.115,
        "w": 0.764,
        "x": 0.118,
        "y": 0.145
      },
      "kind": "paragraph",
      "text": "Eurofins recently responded in writing to an investor's question that Eurofins' cash is strictly segregated from that of Analytical Bioventures and its subsidiaries. However, two former employees who had some visibility into cash movements indicated that there had been issues with such segregation.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb6995e5-269b-4996-abc9-f6d653e0e67b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.095,
        "w": 0.764,
        "x": 0.118,
        "y": 0.43
      },
      "kind": "paragraph",
      "text": "Optimizing a large public company for malfeasance presumably requires a loyal inner circle who is willing to overlook problems - if not outright participate in them. While Eurofins has had notable turnover of senior management, some long-serving managers seem to be getting informal compensation that we fear could compromise their loyalty to the company (as opposed to Dr. Martin).",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc66880d-2411-4248-bf19-ab330f4d0a26",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.155,
        "w": 0.764,
        "x": 0.118,
        "y": 0.54
      },
      "kind": "paragraph",
      "text": "Svend Aage Linde, the current CEO of Eurofins Nordics, reportedly has done business with Dr. Martin since the 1980s. By the end of 2014, Eurofins seemingly had vacated a property (\"Holstebro\") in Vejen, Denmark owned by Dr. Martin through an entity called International Assets Finance S.á.r.l. In 2016, Dr. Martin effectively gifted Holstebro to Mr. Linde for DKK 1. Dr. Martin's entity recorded a €670,000 loss on the disposal of Holstebro in that year, with Mr. Linde then assuming control.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c6da19b1-843a-4fac-97b4-8d1e7d1dafb7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.764,
        "x": 0.118,
        "y": 0.82
      },
      "kind": "source-note",
      "text": "39-44 References and links to financial statements and LinkedIn profiles.",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c5d20e6e-b67c-4247-b130-faf39259ed1a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.764,
        "x": 0.118,
        "y": 0.095
      },
      "kind": "title",
      "text": "Concerns About Segregation of Eurofins' Cash from Dr. Martin's Entities",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "25bba10b-811d-44d1-9e17-17e7184b5a79",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.055,
        "w": 0.764,
        "x": 0.118,
        "y": 0.365
      },
      "kind": "title",
      "text": "Eurofins' Governance is Optimized for Malfeasance: Seemingly Co-Opted Executives and a Weak Board",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c79470ed-383c-47d2-b117-88273d0da30c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "b7c37001-c066-468d-b421-4e7d2ec6343a",
      "evidence": "The slide explicitly links governance structures to potential malfeasance and personal financial gain.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 30,
      "from": 3,
      "beatId": "3d510a0f-6fd9-45d2-879c-09a0eaf3d1a5",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Expose Contradiction",
      "beatSlug": null,
      "evidence": "The research note presents various contradictions in Eurofins Scientific's financial reporting and disclosures.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}